What is Lucid Diagnostics's price / book?

Lucid Diagnostics (LUCD) reported price / book of 49× in Q1 2026.

What is the long-term trend for Lucid Diagnostics's price / book?

Over 3 years (2021 to 2025), Lucid Diagnostics's price / book has grown at a 55.9% compound annual growth rate (CAGR), from 3.4× to 13.1×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Lucid Diagnostics LUCD Price / book

Price / book at other companies

Castle BiosciencesCSTL

1.6×+0.3×

Guardant HealthGH

36.8×—

Biodesix, Inc.BDSX

15.7×+7.4×

Insight Molecular Diagnostics Inc. Common StockIMDX

89.9×—

Fulgent Genetics, Inc.FLGT

0.5×0.0×

Personalis, Inc.PSNL

2.6×+1.1×

Other financials

Income statement

See full

Revenue$1.3M+51.7%

Gross profit-$369.0K+49.0%

Operating income-$12.1M+3.0%

Net income-$13.9M+48.3%

EPS (diluted)-$0.10+60.0%

Balance sheet

See full

Cash & equivalents$27.9M+10.6%

Total debt$1.6M-35.1%

Total equity$4.0M+174%

Total assets$34.1M+3.9%

Cash flow

See full

Operating cash flow-$12.1M+2.9%

CapEx$215.0K+131%

Free cash flow-$12.3M+1.9%

Valuation

See full

Market cap$204.13M+58.5%

Enterprise value$177.85M+78.0%

P/S39.8×+10.2×

Profitability

See full

Gross margin-66.8%—

Operating margin-959.6%-133pp

Net margin-876.7%-254pp

FCF margin-1,099.6%—

Returns & leverage

See full

Return on equity-710.6%—

Debt / equity0.4×—

Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

market cap/total stockholders equity=49×

Based on the most recent quarter.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lucid Diagnostics's price / book?: Lucid Diagnostics (LUCD) reported price / book of 49× in Q1 2026.
What is the long-term trend for Lucid Diagnostics's price / book?: Over 3 years (2021 to 2025), Lucid Diagnostics's price / book has grown at a 55.9% compound annual growth rate (CAGR), from 3.4× to 13.1×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.